In the human stomach, the peptide trefoil factor family 2 (TFF2) is secreted together with the mucin MUC6 by mucous neck cells (MNCs) and antral gland cells. TFF2 is strongly associated with the gastric mucus and promotes gastric restitution. Here, TFF2 was purified from the human corpus and antrum, respectively, by size-exclusion chromatography, and the N-linked glycan structure at N-15 of the mature peptide was determined. As a hallmark, the unusual monofucosylated N,N′-diacetylhexosediamine (tentatively assigned as GalNAcβ1 → 4GlcNAc, LacdiNAc) modification was detected as the terminal structure of a bi-antennary complex type N-glycan exhibiting also core fucosylation. Replicate analyses did not show microheterogeneities in the fraction of peptide-N-glycosidase F cleaved and permethylated N-glycans when analyzed by matrixassisted laser desorption ionization (MALDI) mass spectrometry (MS). On the glycopeptide level, a minor glycan microheterogeneity was evident in liquid chromatographyelectrospray ionization (ESI)-MS, demonstrating the presence of underfucosylated species. The tryptic TFF2 N-glycopeptide p34-39 (LSPHNR N-glycosylated with Fuc3Hex3HexNAc6) was identified by both ESI-tandem mass spectrometry and MALDI-post-source decay analysis. Lectin analyses with the Wisteria floribunda agglutinin indicated the potential presence of LacdiNAc terminating glycans and revealed minor differences between TFF2 from fundic units, i.e. MNCs, and antral units, i.e. antral gland cells. Strikingly, on the level of the primary structure, there was no indication that the formation of the proposed LacdiNAc structure is cis-controlled by a peptidic determinant related to the published sequences.
Introduction
Trefoil factor family 2 (TFF2) is a secretory peptide comprised of 106 amino acid residues, which belongs to the TFF peptides (Tomasetto et al. 1990; Gött et al. 1996; May et al. 2000 ; for reviews, see Hoffmann et al. 2001; Hoffmann and Jagla 2002) . It was discovered originally in the porcine pancreas where it was termed "pancreatic spasmolytic polypeptide" (Jorgensen et al. 1982; Rose et al. 1989 ). However, in human, the major expression site of TFF2 is the stomach (Tomasetto et al. 1990) where it is secreted together with the mucin MUC6 by cardiac glands, mucous neck cells (MNCs) and antral gland cells (Hanby et al. 1993; Ota et al. 2006) . The majority of human TFF2 is N-glycosylated at N-15 and only little TFF2 is non-glycosylated (May et al. 2000) . This peptide is also a characteristic component of the gastric juice with a concentration of 1.9 μg/mL (Kubota et al. 2011) with dramatic diurnal variations between 0.3 and 15 μg/mL (Semple et al. 2001; Johns et al. 2005) . However, porcine, murine and rat TFF2 are lacking N-glycosylation sites. Of special note, TFF2 encoding mRNA is present in MNC precursors, whereas the TFF2 peptide is detectable only in mature MNCs as shown for human (Kouznetsova et al. 2011) , mouse (Quante et al. 2010 ) and rat (Jeffrey et al. 1994) .
Ectopic secretion of TFF2 occurs during inflammatory conditions particularly by a specific gland-like structure termed the ulcer-associated cell lineage (Wright et al. 1990 ) as well as by many tumors (for reviews, see Hoffmann et al. 2001; Hoffmann and Jagla 2002) . Ectopic TFF2 synthesis is also observed in typical stone diseases, such as hepatolithiasis, dacryolithiasis, cholecystolithiasis and nephrolithiasis (Rinnert et al. 2010) . Furthermore, TFF2 is up-regulated in an animal model of gastric ulceration as an early response gene (Wong et al. 2000) , as well as in response to interferon γ (Kang et al. 2005) . Also, it is typical of the TFF2/spasmolytic polypeptide expressing metaplasia, which is a premalignant condition for the "intestinal" type of gastric cancer (Schmidt et al. 1999) .
Different functional aspects of TFF2 have been reported in the past. On the one hand, gastric TFF2 is strongly associated with mucins Kouznetsova et al. 2007 ) and it changes the rheological properties of mucus (Thim et al. 2002; Kjellev et al. 2006) , and it is a characteristic constituent of the alternating laminated structure of the gastric surface mucous gel layer where it co-localizes with MUC6 Suzuki et al. 2006) . On the other hand, TFF2 shows relatively weak "motogenic" effects in vitro (Tu et al. 2009 ; for review, see Hoffmann and Jagla 2002) , and it has been reported to both promote and inhibit apoptosis and to promote the branching morphology of certain cells (Lalani et al. 1999; Tu et al. 2009; Paunel-Görgülü et al. 2011) . TFF2 binds to CRP-ductin/DMBT1 from porcine stomach (Thim and Mortz 2000) and CXCR4 has been reported to be a low-affinity receptor for TFF2 for review, see Hoffmann 2009 ). TFF2 is also expressed in immune cells and participates in immune responses and inflammatory processes, which are dysregulated in Tff2-deficient mice (Baus-Loncar et al. 2005; Kurt-Jones et al. 2007 ). The reference interval of TFF2 in human serum has been reported to as 37-190 pmol/L (Vestergaard et al. 2004 ).
In the past, attempts failed to detect human TFF2 using common lectins that typically recognize N-linked glycans of the high-mannose or complex type (Kouznetsova and Hoffmann, unpublished) . Thus, we purified TFF2 from the human stomach and analyzed the N-linked carbohydrate moiety. Here, we demonstrate the highly specific formation of fucosylated N,N′-diacetyllactosediamine (GalNAcβ1 → 4GlcNAc; LacdiNAc) on human gastric TFF2.
Results
Purification and identification of TFF2 from the human stomach Extracts from human corpus (M382 and M400) or antrum (M323) of three individuals were subject to size-exclusion chromatography (SEC) under non-reducing conditions. The fractions were semi-quantitatively analyzed for their TFF2 content by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (SDS-PAGE) followed by western blot analysis. TFF2 was detectable in the high-molecular-weight fraction, because TFF2 forms a stable heteromeric complex with mucins (Kouznetsova et al. 2007 ). Thus, further purification of monomeric TFF2 was achieved using SDS-PAGE under reducing conditions. After Coomassie staining, the appropriate bands (B18; Figure 1 ) were excised for in-gel trypsin digestion and subjected to liquid chromatography (LC)-electrospray ionization-tandem mass spectrometry (ESI-MS/MS) analysis. TFF2 was clearly identified in all samples from the corpus and antrum, respectively (Supplementary data, Table S1 ).
Analysis of N-linked glycans on TFF2
Analysis of N-linked glycan chains on TFF2 (B18, Figure 1 ) was performed by following an established gel-based protocol. Of note, all other proteins identified with significant high scores in B18 are not listed as N-linked glycoproteins in the libraries or lack even the consensus sequence for N-glycosylation. The permethylated glycans were finally characterized with respect to their monosaccharide compositions and sequences by matrix-assisted laser desorption ionizationmass spectrometry (MALDI-MS) and MALDI-MS/MS analyses. Two biological replicates of TFF2 preparations from human stomach antrum (M323) and corpus (M382), respectively, revealed that the single putative N-glycosylation site at N-15 in the mature human TFF2 peptide (i.e. at N-38 in the precursor) was substituted with a bi-antennary complex-type N-glycan (Figure 2 ). The mass of the molecular ion (MNa at m/z 2675) or its oxonium ion (MH-32 at m/z 2621) matches the monosaccharide composition Fuc3Hex3HexNAc6. No microheterogeneity of glycans at this site became apparent in the survey spectrum. On MS/MS analysis, evidence for a potential core-fucosylation of the reducing HexNAc and of two fucosylated dihexosediamine termini was obtained (Figure 3 ). Under laser-induced dissociation (LID) conditions, strong B-ions were detected on the post-source decay (PSD)-fragmentation of the ion at m/z 2621 corresponding to B 1 (m/z 260) indicating terminal HexNAc, B 2 (m/z 679) indicating terminal dHex1HexNAc2, together with intense internal fragments B 2 Z 5 (m/z 473) or C 2 Z 5 (m/z 491) and Z 5 Y 3 (m/z 1564; refer also to the insert in Figure 3A for structural interpretation). Similarly, the molecular ion of the sodium adduct at m/z 2674 revealed a C 1 + Na ion (m/z 300), and the B ions B 1 + H (m/z 260) or B 1 + Na (m/z 282) and B 2 + Na (m/z 701). Besides these terminal fragments, a complex series of internal fragments was detected at m/z 268, 442, 1114, 1318, 1545, 1604 and 1737 (refer to the insert in Figure 3B for fragment annotation and structural interpretation and to Table S1 ) as well as glycan analysis (M323 and M382) later on. The molecular size standard is indicated "left" and "right", respectively.
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reference Ceroni et al. 2008) . m/z 867 (nominal mass 866) may relate to m/z 1318 and represent a B5 ion derived from Y4/Y4 having lost both antennae. The linkages of the three fucose residues cannot be assigned on the basis of these MS2 data, but the location of the deoxyhexoses at the core-HexNAc or at the antennary dihexosediamines can tentatively be inferred from ESI-MS/MS and MALDI-PSD data obtained on the glycopeptide level (see section Analysis of N-glycopeptides from TFF2). The structural interpretation of terminal trisaccharides in the two glycan antennae as fucosylated LacdiNAc is only partly supported by the above reported MS data. Due to the scarcity of material, no linkage analyses were performed to enable a discrimination between 3-and 4-linked terminal dihexosamines. Hence, the assignment remains tentative, but LacdiNAc represents the most likely structural interpretation based on the published evidences and on further evidence from western blot analyses (see below).
Analysis of N-glycopeptides from TFF2
LC-MS/MS analyses of a tryptic digest of the gel bands B18 (representing glycosylated TFF2) or B14 (representing non-glycosylated TFF2; see Figure 1 ) of a TFF2-enriched preparation from human corpus (M400) were performed in order to verify that N-glycans liberated from TFF2 preparations were indeed derived from the target protein.
The hexapeptide LSPHNR ( p34-39) of human TFF2 carrying the dodecasaccharide Fuc3Hex3HexNAc6 (calculated monoisotopic mass MH 2867.2) was detected in B18 in the eluate at 1.1 min as the triply charged MH ion species at m/z 956.4. MS2 of the signal revealed the formation of intense sugar oxonium ions at m/z 204, 350, 407 and 553 corresponding to terminal HexNAc, FucHexNAc, HexNAc2 and FucHexNAc2 moieties ( Figure 4A ). A minor microheterogeneity was indicated by a triply charged signal eluting at 1.3 min (MH 859.5), which corresponds to the same peptide carrying FucHex3HexNAc6.
Analysis of the sample by positive ion MALDI-MS revealed the presence of a signal at m/z 2866.9 ( Figure 4B ), which is in agreement with the deconvoluted mass of the triply charged ion at m/z 956.4 detected in ESI-MS. On MS2, this signal yielded intense ion series resulting from consecutive sugar cleavage and an intense ion triplet at m/z 723.7 (Mp, molecular mass of the unglycosylated hexapeptide LSPHNR), Mp − 17 and Mp + 83, which is characteristic for N-glycopeptides. Although under collision-induced dissociation (CID) conditions in ESI-MS no peptide fragments were detectable, minor signals were found under PSD-LID conditions corresponding to the y-17 series (y5 at m/z 593.4; y4 at m/z 506.4).
Fig. 2. N-Glycans isolated from TFF2 from the gastric antrum (M323) (A) or the corpus (M382) (B)
. The Coomassie-stained gel bands (B18, see Figure 1 ) were excised, the glycoprotein in-gel digested with pronase E and the eluted glycopeptides off-gel treated with PNGase F to liberate N-linked glycans. The survey MALDI mass spectrum shows dominant signals at m/z 2675.6 (MNa) or of the corresponding oxonium ion at m/z 2621.5 (MH-32) corresponding to a permethylated glycan with the composition Fuc3Hex3HexNAc6. The oxonium ion is formed by loss of sodium methylate (M-54). Signals marked by an asterisk indicate unidentified non-carbohydrate components.
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Lectin analyses TFF2 was enriched from the fundus and antrum, respectively, from six individuals by SEC (high-molecular-weight fraction). The oligosaccharides were probed after western blotting with the help of various lectins in order to verify the structure of the N-linked oligosaccharide of TFF2, to look for individual heterogeneities of TFF2 and to systematically compare TFF2 from the fundus/corpus and antrum. The following lectins were used: lens culinaris agglutinin (LCA) (from Lens culinaris; sugar specificity: branched α-Man containing a core fucose residue), pisum sativum agglutinin (PSA) (from Pisum sativum; sugar specificity: same as LCA), ricinus communis agglutinin (RCA)-II (from Ricinus communis; sugar specificity: terminal β-Gal, β-GalNAc, lactose), SNA (from Sambucus nigra; sugar specificity: sialic acid) and wisteria floribunda agglutinin (WFA) (from W. floribunda; sugar specificity: terminal GalNAc). WFA has previously been shown to bind preferentially to β4-linked GalNAc as found in the LacdiNAc moiety (Ikehara et al. 2006) .
All lectins recognized the same band when compared with immunostained TFF2 (Figure 5 ). There were only little individual differences detectable. However, staining with LCA appeared somewhat stronger in the antral specimens when compared with those of the fundic region. SNA only stained faintly some antral specimens, whereas a weak WFA staining was restricted to fundic specimens.
In order to unambiguously show that lectin staining of TFF2 is exclusively linked to N-glycosylation, the N-linked sugar moiety was specifically removed by the use of peptide-N-glycosidase F (PNGase F) and the digested samples were probed with the lectins ( Figure 5B ). As expected, the loss of the N-linked sugar moiety was accompanied by the loss of lectin staining, whereas TFF2 immunoreactivity was clearly not lost after PNGase F digestion.
Discussion
Here, we show that TFF2 from human stomach contains the unusual LacdiNAc modification as the terminal structure of its N-linked glycan. This peripheral modification represents a unique protein-specific glycosylation found on a restricted panel of glycoproteins pointing to a highly controlled biosynthesis. The LacdiNAc motif appears to play crucial roles in the regulation of circulatory half-life of hormones (Manzella et al. 1996) , in cell recognition (Lowe and Marth 2003) and in the self-renewal of mouse embryonic stem cells (Sasaki et al. 2011) . The N-linked modification was detected in a series of mammalian glycoproteins including luteinizing hormone (Green et al. 1985) , thyroid-stimulating hormone (Green and Baenziger 1988; Hiyama et al. 1992) , glycodelin (Dell et al. 1995) , prolactin-like proteins (Manzella et al. 1997) , pro-opiomelanocortin (Skelton et al. 1992) , lowdensity lipoprotein receptor homolog SorLA/LR11 (Fiete et al. 2007 ), sialoadhesin (Martinez-Pomares et al. 1999) , tenascin-R (Woodworth et al. 2004) , carbonic anhydrase VI (Hooper et al. 1995) and certain bovine membrane proteins (Sakiyama et al. 1998) .
Beyond this, the structure was also found as a terminal modification of O-linked core 2-type glycans on the Fig. 3 . MS/MS analysis by PSD-LID fragmentation of glycans from human gastric TFF2 (refer to Figure 2A and B) . N-Glycans isolated from TFF2 from the gastric antrum (A) or the corpus (B) exhibit identical structures characterized by fucosylated dihexosediamine trisaccharides in both complex-type antennae and by a core fucosylation. The structures were deduced from intense B, C, Y and Z ions and from internal fragments as annotated and shown in the inserted structural models (Ceroni et al. 2008) .
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neuropeptide hormone pro-opiomelanocortin and on a series of extracellular matrix (ECM) proteins (Breloy et al. 2012) . Although it was known already that LacdiNAc could be further modified by fucosylation, sialylation or sulfation, it was demonstrated recently that also phosphorylated LacdiNAc occurs on these ECM proteins (Breloy et al. 2012) .
The sulfated LacdiNAc structure (SO 4 → 4LacdiNAc1 → 2Manα) is specifically recognized by a hepatic reticuloendothelial receptor (Fiete et al. 1991 ) and the closely related macrophage mannose receptor from the lung (Fiete et al. 1997 ). In the latter, a cysteine-rich domain is responsible for specific binding (Fiete et al. 1998) . Furthermore, fucosylated LacdiNAc antennae have been shown to potently block selectin-mediated adhesions in a Ca 2+ -dependent fashion (Grinnell et al. 1994) . This was hypothesized to be the reason for the contraceptive function of glycodelin (Dell et al. 1995) . The LacdiNAc structure is also required for the stable localization of certain receptors within lipid raft/caveolar compartments (Sasaki et al. 2011) .
Formation of the LacdiNAc structure requires the βGalNAc transferase activity. Thus far, two such enzymes have been characterized, i.e. β4GalNAc-T3 (βGT3) and β4GalNAc-T4 (βGT4), which show different tissue distributions (Sato et al. 2003; Gotoh et al. 2004) . Recently, both enzymes were demonstrated to transfer GalNAc in a peptide-specific (cis-controlled) fashion (Fiete et al. 2012) . Of note, β-N-acetylgalactosaminylation by βGT3 or βGT4 can be induced by a single-peptide recognition determinant where a 19-meric peptide sequence within the target protein (LRRFIEQKITKRKKEKYWP) is necessary and sufficient (Miller et al. 2008 ). This cis-controlling determinant (located at the C-terminus of carbonic anhydrase VI) is characterized by a high content of basic amino acids and an α-helical structure (for review, see Hanisch and Breloy 2009 ). Interestingly, the N-glycosylation site of TFF2, localized within loop 1, is flanked by proline residues and is very close to a turn (based on the three-dimensional structures of porcine TFF2; Carr et al. 1994; De et al. 1994 ). Thus, the N-glycosylation site of TFF2 certainly reflects a topologically highly exposed determinant, which should be recognized by βGT3 or βGT4.
However, a determinant related in its primary structure to the 19-meric peptide (Miller et al. 2008 ) is not found in human TFF2 (as well as in most glycoproteins bearing an O-linked LacdiNAc glycan structure). Thus, it is intriguing to speculate that the 19-meric peptide motif may only reflect the need to attain a specific secondary structure.
The results from the lectin analyses ( Figure 5 ) are in agreement with the proposed glycan structure. The strong reactivity with RCA-II is due to the terminal βGalNAc structure, whereas the binding of LCA and PSA confirms the fucosylation of the antennae or of the glycan core. The slightly different reactivity with LCA might be an indication for a somewhat higher fucosylation of TFF2 in the antrum when compared with the corpus. There was also faint binding of SNA observed in antral specimens, indicating that TFF2 might be sialylated to very low extent in the antrum only. Furthermore, also weak reactivity with WFA was observed in fundic specimens only. This lectin is well known to recognize the LacdiNAc structure ( particularly the terminal βGalNAc residue); however, LacdiNAc structures modified by sulfation, fucosylation or sialylation are not recognized any more (Sakiyama et al. 1998; Ikehara et al. 2006 ). Thus, a small portion of fundic TFF2 seems to contain a non-fucosylated LacdiNAc structure recognized by WFA, whereas the LacdiNAc structure of antral TFF2 is modified mainly by fucosylation and to minor extent by sialylation, which both mask the reactivity with WFA. Taken together, the glycosylation of TFF2 seems to differ somewhat in the antrum when compared with the fundus/corpus region. This is not surprising because TFF2 is synthesized in fundic units in MNCs, whereas antral TFF2 synthesis occurs in antral gland cells. Both cell types are very similar, e.g. both secrete TFF2 and the mucin MUC6; but they also differ significantly, for example, by their synthesis of pepsinogen A, which is lacking in antral gland cells (Kouznetsova et al. 2011) .
Thus far, it is not known precisely how the LacdiNAc structure of TFF2 is formed. The predominant βGalNAc transferase in the human stomach is βGT3 (Gotoh et al. 2004 ). However, βGT3 has been reported to be localized mainly in surface mucous cells, which do not synthesize TFF2, as well as in a minority of cells of the fundic glands, which might be MNCs (Ikehara et al. 2006) . Prominent localization of βGT3 in surface mucous cells is in perfect agreement with a recent report that the gastric mucin MUC5AC (which is a secretory product of surface mucous cells) contains an O-linked LacdiNAc epitope (Kenny et al. 2012) and that surface mucous cells react intensely with WFA (Ota et al. 1991; Kenny et al. 2012) .
The functional significance of the LacdiNAc-containing glycan structure of TFF2 is not known thus far. It could influence the half-life and/or activity of TFF2. This assumption would be in line with the report that glycosylated recombinant TFF2 is slightly more potent than the non-glycosylated form in decreasing the amount of gastric damage in vivo (Playford et al. 1995) . By analogy with other glycoprotein hormones (Manzella et al. 1996) , it is tempting to speculate that the half-life of TFF2 particularly in the human serum is regulated by its N-linked glycosylation. Furthermore, termination of glycosylation of TFF2 with LacdiNAc could be in were purified by SEC (on Superose 6 or Sephacryl S-300, respectively) and the high-molecular-weight fractions were separated by 15% SDS-PAGE under reducing conditions followed by western blot analysis using the affinity-purified antisera anti-hTFF2-1 or anti-hTFF2-3 or the following lectins: RCA-II, LCA, PSA, SNA and WFA. The molecular size standard is shown in "left". As a standard for the lectin analyses, TFF2 from a gastric extract was identified via antiserum anti-hTFF2-1 (right). (B) Purified fundic extract (M461, see Figure 5A ) was digested with PNGase F and analyzed after western blotting ( Figure 5A ) with the affinity-purified antiserum anti-hTFF2-1 or the following lectins: RCA-II and PSA. The molecular size standard is shown in left. C, undigested controls; F, samples digested with PNGase F.
competition with complex glycosylations, which are known to bind Helicobacter pylori adhesins (Kenny et al. 2012) . Thus, the glycosylation of TFF2 might be another determinant influencing the colonization of the human stomach with H. pylori. Remarkably, TFF2 levels were significantly higher in patients with H. pylori infection (Kubota et al. 2011) , and also the diurnal rhythm of TFF2 is influenced by H. pylori (Johns et al. 2005) . However, porcine, murine and rat TFF2 are lacking N-glycosylation sites. Of special note, the functional homologs of TFF2 in Xenopus laevis (xP4.1 and xP4.2) are encoded by two different genes, only one bearing an N-glycosylation site (xP4.1; Hauser and Hoffmann 1991; Botzler et al. 1999) . Interestingly, glycosylated xP4.1 is expressed in all regions of the stomach, whereas nonglycosylated xP4.2 is restricted to the fundus and corpus (Jagla et al. 1998; Hoffmann and Jagla 2002) . Thus, N-glycosylation of TFF2 and its functional homologs are already observed early in evolution and might influence microbial colonization particularly of the antrum of certain species including human.
Materials and methods

Human tissue
All investigations followed the tenets of the Declaration of Helsinki and were approved by the Ethic Committee of the Medical Faculty of the University of Magdeburg. Human gastric tissue (fundus/corpus and antrum, respectively) was investigated from nine patients (M257, M323, M354, M381, M382, M400, M461, M462 and M463) undergoing gastrectomy because of carcinoma or sleeve resection because of adipositas. Samples were included in the study only when the formal histopathological review of the specimens excluded neoplastic changes.
Extraction of proteins from human gastric tissue
Human gastric specimens (0.3-2.0 g tissue stored at -80°C) were cut into small pieces, suspended in a 4-fold amount (w/v) of extraction buffer (30 mM NaCl, 20 mM Tris-HCl, pH 8.0) including protease inhibitors (0.5 mM benzamidine, 0.1 mM Pefabloc SC, 1 μg/mL leupeptin) and frozen in liquid nitrogen. Further extraction was with a Precellys ® 24 lyser/homogeniser (Peqlab Biotechnologie GmbH, Erlangen, Germany; 3-4 × 20 s, 6800 rpm). After centrifugation (16,000 × g, 10 min, 4°C), the supernatant was extracted with an equal amount of chloroform and centrifuged again under the same conditions. The aqueous phase (extract) was the subject of western blot analysis and then applied on a gel filtration column.
Protein purification by SEC The gastric extract (8 mL) was fractioned by SEC on a Sephadex G-200 (Fluka, Taufkirchen, Germany) column (260 × 40 mm) similar as described by Kouznetsova et al. (2007) . The flow rate was 0.75 mL/min. The elution profile was monitored by measuring the absorbance at 280 nm. Seventy-four fractions were collected (6.8 mL each). Alternatively, SEC (2 mL) was performed with the ÄKTA™-FPLC system (Amersham Biosciences, Freiburg, Germany) using one of the following columns (from GE Healthcare Bio-Sciences AB, Uppsala, Sweden): HiPrep 16/60 Sephacryl S-500 High Resolution (flow rate: 0.5 mL/min, 1.8 mL fractions), HiPrep 16/60 Sephacryl S-300 High Resolution (flow rate: 0.5 mL/ min, 1.8 mL fractions) or Superose 6 (flow rate: 0.5 mL/min, 1.0 mL fractions). Elution was with 20 mM Tris-HCl (pH 8.0) + 30 mM NaCl including protease inhibitors (0.5 mM benzamidine, 0.1 mM Pefabloc SC, 1 μg/mL leupeptin). The elution profile was monitored by measuring the absorbance at 280 nm.
PNGase F digestion TFF2 enriched by SEC was denatured by boiling in 0.09% β-mercapto-ethanol for 3 min, cooled on ice and incubated with 20 units PNGase F (Roche Diagnostics GmbH, Mannheim, Germany) in the presence of 50 mM Na 2 HPO 4 , pH 7.0, at 37°C for 16 h according to the manufacturer's instructions. Then, the proteins were precipitated by adding 4 volumes of cold acetone (−20°C) and the pellet was subject to western blot or lectin analysis.
SDS-PAGE and western blot analysis PAGE under reducing conditions, protein staining with Bio-Safe Coomassie Stain (Bio-Rad Laboratories GmbH, Munich, Germany), and silver staining were described by Albert et al. (2010) .
Western blot analysis after SDS-PAGE, electrophoretic transfer and fixation with 0.2% glutaraldehyde were according to previous reports (Jagla et al. 1998; Kouznetsova et al. 2007) . TFF2 was detected with a specific polyclonal antiserum. Bands were visualized with the enhanced chemiluminescence (ECL) detection system and semi-quantitative analysis of the bands using the Gene Tools Gel analysis software (Syngene, Cambridge, UK) was performed as described in detail (Kouznetsova et al. 2007 ).
Alternatively, TFF2 was detected with the help of various biotinylated lectins followed by binding of streptavidin-peroxidase and visualization with ECL. The biotinylated lectins were used in a 1:500 to 1:1000 dilution in 1% gelatin.
Antisera, lectins
The affinity-purified polyclonal antiserum anti-hTFF2-1 (Jagla et al. 2000) against the peptide FFPNSVEDCHY recognizing the C terminus of human TFF2 was used. Furthermore, based on the TFF2 sequence reported by May et al. (2000) , the polyclonal antiserum anti-hTFF2-3 was generated by coupling the synthetic peptide FFPKSVEDCHY to keyhole limpet hemocyanin with glutaraldehyde and immunizing a rabbit. The secondary antibody was a horseradish peroxidase labeled antirabbit IgG(H + L) (PI-1000, Vector Laboratories, Burlingame, USA).
The following biotinylated lectins were used: LCA (from L. culinaris; Vector Laboratories), PSA (from P. sativum; Vector Laboratories), RCA-II (from R. communis; SigmaAldrich Chemie, Taufkirchen, Germany), SNA (from S. nigra; Vector Laboratories) and WFA (from W. floribunda; Vector Laboratories). 
LC-ESI-MS/MS analysis of in-gel digested proteins
Trypsin digestion of Coomassie stained protein bands, the performance of LC-MS/MS data and database searching have previously been described in detail (Albert et al. 2010) . Applying DataAnalysis 4.0 software (Bruker) glycopeptides were identified by searching ion traces corresponding to glycan-derived oxonium ions at m/z 204 (HexNAc), 350 (dHexHexNAc), 407 (HexNAc2) and 553 (dHexHexNAc2).
N-Glycan analysis In-gel protease digestion. Coomassie-stained gel pieces were excised, washed once for 1 h with 1 mL water and twice for 1 h with 1 mL 50% acetonitrile, dried by vacuum rotation, equilibrated with pronase-buffer (50 mM NH 4 HCO 3 containing 1 mM CaCl 2 ) for 1 h and dried again by vacuum rotation. Pronase E (10 mg in 1 mL buffer) digestion was performed overnight at 37°C. (Glyco)peptides were eluted with 200 mL water (two times) and 200 mL 50% acetonitrile/water for 1 h each, heated to 90°C for at least 10 min and dried in a speedvac before PNGase F digestion.
Off-gel enzymatic cleavage and permethylation of N-glycans. The glycan chains were released from the pronase-stable glycopeptides by addition of 0.5 µL PNGase F (250 U, New England BioLabs GmbH, Frankfurt/M., Germany) in 50 µL of 50 mM NH 4 HCO 3 , pH 8.0. After overnight incubation at 37°C, the reaction mixture was dried by vacuum rotation and taken up in 50 µL water prior to application on activated C18 BondElut columns. The flow-through containing the N-glycans was collected and dried by vacuum rotation followed by desiccation over P 2 O 5 (up to 1 h) before permethylation of glycans according to Ciucanu and Kerek (1984) .
Glycan analysis by MALDI-time-of-flight/time-of-flight MS MALDI-MS was performed on an UltrafleXtreme instrument (Bruker Daltonics, Bremen, Germany). The permethylated glycans contained in methanol were applied to the stainless steel target by mixing a 0.5-µL aliquot of sample with 1.0 µL of matrix [saturated solution of 2,5-dihydroxy benzoic acid in acetonitrile/0.1% trifluoroacetic acid (TFA), 1:2]. Alternatively, the samples in methanol (0.75 µL) were mixed on target with an equal volume of a-cyano-4-hydroxy-cinnamic acid (saturated solution in 50% acetonitrile/aqueous TFA). Analyses were performed by positive-ion detection in the reflectron mode. Ionization of co-crystallized analytes was induced with a pulsed Smart-beam laser (accumulation of 5.000 shots) and the ions were accelerated in a field of 20 kV and reflected at 23 kV. MALDI-MS/MS was performed by analysis of PSD fragments in the LID mode. Fragment annotation was assisted by the application of the GlycoWorkbench tool (Ceroni et al. 2008) .
Supplementary data
Supplementary data for this article is available online at http ://glycob.oxfordjournals.org/.
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